Targeting of acetylcholinesterase to lipid rafts of muscle

Chemico-Biological Interactions

Volumn 175, Issue 1-3, 2008, Pages 312-317

  Moral Naranjo, M T ^a   Montenegro, M F ^a   Munoz Delgado E ^a   Campoy, F J ^a   Vidal, C J ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

Congenital muscular dystrophy; DIGs; GPI anchored proteins; Laminin 2

Indexed keywords

ACETYLCHOLINESTERASE; CAVEOLIN 3; CHOLINERGIC RECEPTOR; DIMER; DYSTROPHIN; ECTO 5' NUCLEOTIDASE; GLYCOSYLPHOSPHATIDYLINOSITOL; MEROSIN; MUSCARINIC RECEPTOR; NICOTINIC RECEPTOR; PHOSPHOLIPASE C; TRITON X 100;

ANIMAL TISSUE; ARTICLE; CAVEOLA; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVITY; LIPID RAFT; MOUSE; MUSCULAR DYSTROPHY; NEUROMUSCULAR SYNAPSE; NONHUMAN; PROTEIN TARGETING; REGULATORY MECHANISM; SARCOLEMMA;

ACETYLCHOLINESTERASE; ANIMALS; LIPID METABOLISM; MUSCLES;

MUS;

EID: 50649125121     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2008.04.018     Document Type: Article

References (30)

1. Jiménez-Mallebrera C., Brown S.C., Sewry C.A., and Muntoni F. Congenital muscular dystrophy: molecular and cellular aspects. Cell. Mol. Life Sci. 62 (2005) 809-823
2. Lisi M.T., and Cohn R.D. Congenital muscular dystrophies: new aspects of an expanding group of disorders. Biochim. Biophys. Acta 1772 (2007) 159-172
3. Moral-Naranjo M.T., Cabezas-Herrera J., Vidal C.J., and Campoy F.J. Muscular dystrophy with laminin deficiency decreases the content of butyrylcholinesterase tetramers in sciatic nerves of Lama2dy mice. Neurosci. Lett. 331 (2002) 155-158
4. Garner A.E., Smith D.A., and Hooper N.M. Sphingomyelin chain length influences the distribution of GPI-anchored proteins in rafts in supported lipid bilayers. Mol. Membr. Biol. 24 (2007) 233-242
5. Hanzal-Bayer M.F., and Hancock J.F. Lipid rafts and membrane traffic. FEBS Lett. 581 (2007) 2098-2104
6. Hnasko R., and Lisanti M.P. The biology of caveolae: lessons from caveolin knockout mice and implications for human disease. Mol. Intervent. 3 (2003) 445-463
7. Allen J.A., Halverson-Tamboli R.A., and Rasenick M.M. Lipid rafts microdomains and neurotransmitter signalling. Nat. Rev. Neurosci. 8 (2007) 128-140
8. Stetzkowski-Marden F., Gaus C., Recouvreur M., Cartaud A., and Cartaud J. Agrin elicits membrane lipid condensation at sites of acetylcholine receptor clusters in C2C12 myotubes. J. Lipid Res. 47 (2006) 2121-2133
9. Massoulié J., Bon S., Perrier N., and Falasca C. The C-terminal peptides of acetylcholinesterase: cellular trafficking, oligomerization and functional anchoring. Chem. Biol. Interact. 157/158 (2005) 3-14
10. Meshorer E., and Soreq H. Virtues and woes of AChE alternative splicing in stress-related neuropathologies. Trends Neurosci. 29 (2006) 216-224
11. Nieto-Cerón S., Sánchez del Campo L.F., Muñoz-Delgado E., Vidal C.J., and Campoy F.J. Muscular dystrophy by merosin deficiency decreases acetylcholinesterase activity in thymus of Lama2dy mice. J. Neurochem. 95 (2005) 1035-1046
12. Cabezas-Herrera J., Moral-Naranjo M.T., Campoy F.J., and Vidal C.J. Glycosylation of acetylcholinesterase forms in microsomal membranes from normal and dystrophic Lama2dy mouse muscle. J. Neurochem. 69 (1997) 1964-1974
13. Rotundo R.L., Rossi S.G., Kimbell L.M., Ruiz C., and Marrero E. Targeting acetylcholinesterase to the neuromuscular synapse. Chem. Biol. Interact. 157/158 (2005) 15-21
14. Guerra M., Cartaud A., Cartaud J., and Legay C. Acetylcholinesterase and molecular interactions at the neuromuscular junction. Chem. Biol. Interact. 157/158 (2005) 57-61
15. Vaghy P., Fang J., Wu W., and Vaghy L. Increased caveolin-3 levels in mdx mouse muscles. FEBS Lett. 431 (1998) 125-127
16. Repetto S., Bado M., Broda P., Lucania G., Masetti E., Sotgia F., Carbone I., Pavan A., Bonilla E., Cordone G., Lisanti M.P., and Minetti C. Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy. Biochem. Biophys. Res. Commun. 261 (1999) 547-550
17. Galbiati F., Engelman J.A., Volonte D., Zhang X.L., Minetti C., Li M., Hou H., Kneitz B., Edelmann W., and Lisanti M.P. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and T-tubule abnormalities. J. Biol. Chem. 276 (2001) 21425-21433
18. Ruiz-Espejo F., Cabezas-Herrera J., Illana J., Campoy F.J., Muñoz-Delgado E., and Vidal C.J. Breast cancer metastasis alters acetylcholinesterase activity and the composition of enzyme forms in axillary lymph nodes. Breast Cancer Res. Treat. 80 (2003) 105-114
19. Martínez-Martínez A., Muñoz-Delgado E., Campoy F.J., Flores-Flores C., Rodríguez-López J.N., Fini C., and Vidal C.J. The ecto-5′-nucleotidase subunits in dimers are not linked by disulfide bridges but by non-covalent bonds. Biochim. Biophys. Acta 1478 (2000) 300-308
20. Moral-Naranjo M.T., Cabezas-Herrera J., and Vidal C.J. Molecular forms of acetyl- and butyrylcholinesterase in normal and dystrophic mouse brain. J. Neurosci. Res. 43 (1996) 224-234
21. Shibuya S., Wakayama Y., Inoue M., Kojima H., and Oniki H. Merosin (laminin-2) localization in basal lamina of normal skeletal muscle fibers and changes in plasma membrane of merosin-deficient skeletal muscle fibers. Med. Electron. Microsc. 36 (2003) 213-220
22. Galbiati F., Volonté D., Chu J.B., Li M., Fine S.W., Fu M., Bermudez J., Pedemonte M., Weidenheim K.M., Pestell R.G., Minetti C., and Lisanti M.P. Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 9689-9694
23. Matschke K., Babiychuk E.B., Monastyrskaya K., and Draeger A. Phenotypic conversion leads to structural and functional changes of smooth muscle sarcolemma. Exp. Cell Res. 312 (2006) 3495-3503
24. Legay C., Huchet M., Massoulié J., and Changeux J.P. Developmental regulation of acetylcholinesterase transcripts in the mouse diaphragm: alternative splicing and focalization. Eur. J. Neurosci. 7 (1995) 1803-1809
25. Xie H.Q., Choi R.C., Leung K.W., Siow N.L., Kong L.W., Lau F.T., Peng H.B., and Tsim K.W. Regulation of a transcript encoding the proline-rich membrane anchor of globular muscle acetylcholinesterase. The suppressive roles of myogenesis and innervating nerves. J. Biol. Chem. 282 (2007) 11765-11775
26. Gómez J.L., Moral-Naranjo M.T., Campoy F.J., and Vidal C.J. Characterization of acetylcholinesterase and butyrylcholinesterase forms in normal and dystrophic Lama2dy mouse heart. J. Neurosci. Res. 56 (1999) 295-306
27. Gómez J.L., García-Ayllón M.S., Campoy F.J., and Vidal C.J. Muscular dystrophy alters the processing of light acetylcholinesterase but not butyrylcholinesterase forms in liver of Lama2dy mice. J. Neurosci. Res. 62 (2000) 134-145
28. Ruiz-Espejo F., Cabezas-Herrera J., Illana J., Campoy F.J., and Vidal C.J. Cholinesterase activity and acetylcholinesterase glycosylation are altered in human breast cancer. Breast Cancer Res. Treat. 72 (2002) 11-22
29. Vidal C.J. Expression of cholinesterases in brain and non-brain tumours. Chem. Biol. Interact. 157/158 (2005) 227-232
30. Montenegro M.F., Ruiz-Espejo F., Campoy F.J., Muñoz-Delgado E., Páez de la Cadena M., Rodríguez-Berrocal F.J., and Vidal C.J. Cholinesterases are down-expressed in human colorectal carcinoma. Cell. Mol. Life Sci. 63 (2006) 2175-2182